Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AZTRthis companyAzitra, Inc.	$0.70	-0.12×	0.34×	0×	0.03×	226.8%	0.0%	0.0%	0.0%	-288.2%	-259.7%	-883.5%	0.11×	0.16×	-1,445.45×	2.83×	0.0%	2	-11.39	3	B-
ENVBEnveric Biosciences, Inc.	$1.43	-0.1×	0.29×	0×	0.4×	755.2%	0.0%	0.0%	0.0%	-290.4%	-210.0%	-670.1%	0×	0.55×	-82,777.81×	5.38×	0.0%	2	-16.34	2	B-
INDPIndaptus Therapeutics, Inc.	$3.38	-0.13×	0.89×	0×	0.27×	137.0%	0.0%	0.0%	0.0%	-661.5%	-629.3%	-527.3%	0×	0.41×	0×	1.51×	0.0%	2	373.3	2	C
JSPRJasper Therapeutics, Inc.	$15.23	-0.46×	8.45×	0×	-0.1×	128.1%	0.0%	0.0%	0.0%	-1826.1%	-338.1%	-220.0%	0.3×	0.37×	0×	2.62×	0.0%	0	-45.56	2	C+
ONCOOnconetix, Inc.	$3.48	-16.49×	16.24×	313.95×	-18.91×	153.6%	77.6%	-778.2%	-1721.0%	-89.0%	-40.1%	-3.8%	0×	0.39×	-8.45×	0.66×	0.0%	1	-13.08	3	B
REVBRevelation Biosciences, Inc.	$4.19	-0.13×	0.22×	0×	0.88×	2518.1%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	2	-7.62	2	B-
Peer median	—	-0.13×	0.89×	0×	0.27×	153.6%	0.0%	0.0%	0.0%	-290.4%	-210.0%	-416.3%	0×	0.41×	0×	2.62×	0.0%	2	-13.08	2	—